XML 37 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
January 2024 PIPE Transaction
At The Market Sales Agreement
Common Stock
Common Stock
January 2024 PIPE Transaction
Common Stock
At The Market Sales Agreement
Additional Paid-In Capital
Additional Paid-In Capital
January 2024 PIPE Transaction
Additional Paid-In Capital
At The Market Sales Agreement
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022       39,307,286              
Beginning balance at Dec. 31, 2022 $ 113,684     $ 4     $ 427,925     $ 3,035 $ (317,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (25,272)                   (25,272)
Stock-based compensation 1,979           1,979        
Foreign exchange translation adjustment 776                 776  
Shares issued from exercise of pre-funded warrants (in shares)       5,096,552              
Shares issued from exercise of pre-funded warrants 51           51        
Ending balance (in shares) at Mar. 31, 2023       44,403,838              
Ending balance at Mar. 31, 2023 91,218     $ 4     429,955     3,811 (342,552)
Beginning balance (in shares) at Dec. 31, 2022       39,307,286              
Beginning balance at Dec. 31, 2022 113,684     $ 4     427,925     3,035 (317,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (49,271)                    
Foreign exchange translation adjustment 947                    
Ending balance (in shares) at Jun. 30, 2023       44,488,371              
Ending balance at Jun. 30, 2023 69,284     $ 4     431,849     3,982 (366,551)
Beginning balance (in shares) at Mar. 31, 2023       44,403,838              
Beginning balance at Mar. 31, 2023 91,218     $ 4     429,955     3,811 (342,552)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (23,999)                   (23,999)
Stock-based compensation 1,798           1,798        
Foreign exchange translation adjustment 171                 171  
Shares issued in connection with the Company's Employee stock purchase plan (in shares)       84,533              
Shares issued in connection with the Company's Employee stock purchase plan 96           96        
Ending balance (in shares) at Jun. 30, 2023       44,488,371              
Ending balance at Jun. 30, 2023 $ 69,284     $ 4     431,849     3,982 (366,551)
Beginning balance (in shares) at Dec. 31, 2023 45,177,730     45,177,730              
Beginning balance at Dec. 31, 2023 $ 28,931     $ 4     436,060     3,759 (410,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (29,584)                   (29,584)
Stock-based compensation 2,750           2,750        
Foreign exchange translation adjustment 528                 528  
Issuance of common stock (in shares)         44,751,286 150,000          
Issuance of common stock   $ 52,364 $ 191   $ 4     $ 52,360 $ 191    
Conversion of tranche rights liability to equity 28,396           28,396        
Ending balance (in shares) at Mar. 31, 2024       90,079,016              
Ending balance at Mar. 31, 2024 $ 83,576     $ 8     519,757     4,287 (440,476)
Beginning balance (in shares) at Dec. 31, 2023 45,177,730     45,177,730              
Beginning balance at Dec. 31, 2023 $ 28,931     $ 4     436,060     3,759 (410,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (50,964)                    
Foreign exchange translation adjustment $ 23                    
Ending balance (in shares) at Jun. 30, 2024 90,079,016     90,079,016              
Ending balance at Jun. 30, 2024 $ 63,573     $ 8     521,639     3,782 (461,856)
Beginning balance (in shares) at Mar. 31, 2024       90,079,016              
Beginning balance at Mar. 31, 2024 83,576     $ 8     519,757     4,287 (440,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (21,380)                   (21,380)
Stock-based compensation 1,882           1,882        
Foreign exchange translation adjustment $ (505)                 (505)  
Ending balance (in shares) at Jun. 30, 2024 90,079,016     90,079,016              
Ending balance at Jun. 30, 2024 $ 63,573     $ 8     $ 521,639     $ 3,782 $ (461,856)